FDA — authorised 26 April 1996
- Application: NDA020528
- Marketing authorisation holder: ABBVIE
- Local brand name: MAVIK
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Mavik in United States
FDA authorised Mavik on 26 April 1996
Marketing authorisations
FDA
- Status: approved
Other Cardiovascular approved in United States
Frequently asked questions
Is Mavik approved in United States?
Yes. FDA authorised it on 26 April 1996; FDA has authorised it.
Who is the marketing authorisation holder for Mavik in United States?
ABBVIE holds the US marketing authorisation.